Deamidated gliadinIgG high Anti-deamidated gliadin peptide IgA (anti-DGP IgA) is a crucial serological marker used in the diagnosis and monitoring of celiac disease. This test specifically looks for IgA antibodies that the immune system produces in response to deamidated gliadin peptides, which are modified forms of gliadin found in gluten.2024年9月14日—These antibodies aremade against gliadin, a protein found in wheat and other cereals. The newest version of this test is called DGP (deamidated ... Gluten, a protein present in wheat, barley, and rye, triggers an autoimmune response in individuals with celiac disease, leading to damage in the small intestine.IgA antibodies against deamidated gliadin peptides in ... The anti-DGP IgA test, alongside other celiac disease biomarkers, plays a significant role in identifying this condition and assessing its severity.Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG ...
Celiac disease is an autoimmune disorder where the ingestion of gluten leads to an immune system attack on the small intestine. Gliadin is a primary component of gluten, and when it undergoes a process called deamidation (often facilitated by an enzyme called tissue transglutaminase within the body), it becomes more immunogenic. The immune system, mistaking these deamidated gliadin peptides as a threat, produces antibodies against them. The anti-DGP IgA test is designed to detect these specific antibodies.
While anti-gliadin antibodies have been used historically, deamidated gliadin peptide antibodies, including the IgA variant, are considered more specific and sensitive markers for celiac disease. This is because the deamidation process enhances the ability of gliadin peptides to bind to certain immune system molecules, making them more likely to elicit an immune response in susceptible individuals2025年6月13日—Specimen Required. 3 mL plain blood. Indications. Anti-DGP (IgAand IgG) should be combined with theanti-tTGIgAand IgG tests when .... Therefore, detecting anti-DGP IgA can provide a clearer indication of active celiac disease compared to older gliadin antibody tests.Celiac Disease Screening
Positive results for anti-DGP IgA antibodies are consistent with a diagnosis of celiac disease. However, like any diagnostic test, interpretation should always occur within the context of a patient's clinical symptoms and other laboratory findings.
Key considerations for interpretation include:
* IgA Deficiency: A significant portion of individuals with celiac disease may have an IgA deficiency. In such cases, total IgA levels can be low, potentially leading to false-negative results for IgA-based tests like anti-DGP IgA. For individuals with suspected IgA deficiency, testing for IgG antibodies, such as anti-deamidated gliadin peptide IgG (anti-DGP IgG), becomes particularly important. Some guidelines recommend including total IgA testing alongside anti-DGP IgA to screen for IgA deficiencyAnti-Deamidated Gliadin Peptides (DGP) IgA.
* Comparison with Other Markers: Anti-DGP IgA is often used in conjunction with other celiac disease serological markers, most notably IgA tissue transglutaminase (tTG IgA) antibodies.作者：NK Gatselis·2012·被引用次数：23—Although a significant number of patients had detectable CD-related autoantibodies,anti-DGP-IgAtest seems better thananti-tTG-IgAfor ... Combining these tests can enhance diagnostic accuracy. For instance, some research suggests that utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis, especially when IgA deficiency is a concernIn people following a gluten-containing diet, the test forIgA anti-gliadin deamidated peptide(GPD) antibodies has lower diagnostic sensitivity and ....
* Screening vs. Diagnostic Utility: While anti-DGP IgA is a valuable diagnostic tool, its role in initial screening is sometimes debated. Some sources suggest that anti-DGP IgA should not be used for initial screening due to potentially lower specificity and a limited role in identifying all cases of undetected celiac disease compared to other primary markers. However, it is highly effective when used as a confirmatory or supplementary test.作者：GN Catassi·2021·被引用次数：39—The need of adding the determination ofanti-deamidated gliadin peptide (DGP) IgGto anti-transglutaminase (TTG) IgA antibodies for ...
* High Levels: Elevated levels of anti-DGP IgA can indicate active celiac disease. Monitoring these levels over time, particularly after implementing a gluten-free diet, can help assess treatment response and intestinal healing.
The diagnostic landscape for celiac disease involves several autoantibody tests, each with varying sensitivities and specificities. Understanding how anti-DGP IgA fits into this picture is crucial.
* Anti-Tissue Transglutaminase (tTG) Antibodies: IgA anti-tTG is considered the primary serological screening test for celiac disease due to its high sensitivity and specificityAnti-deamidated gliadin peptides (anti-DGP) IgA areautoantibodies that target gliadin peptidesmodified by tissue transglutaminase through deamidation, a .... Anti-DGP IgA is often used as a complementary test, especially when tTG results are borderline or when IgA deficiency is suspected.
* Anti-Gliadin Antibodies (AGA): While older tests for anti-gliadin antibodies (IgG and IgA) were once standard, they are generally less specific and sensitive than anti-DGP and anti-tTG assays.Prevalence of Anti-deamidated Gliadin Peptide Antibodies ... Deamidated gliadin peptide antibodies are preferred because they target more immunogenic forms of gliadin.
* Anti-Endomysial Antibodies (EMA): EMA are highly specific for celiac disease but are less sensitive and more difficult to perform than tTG or DGP assays. They are typically used as a confirmatory test.
The evolution of celiac disease serology has led to the development and increased utilization of newer antibodies like anti-DGP IgA and IgG. These newer markers, particularly when used in combination, offer improved diagnostic accuracy and can aid in identifying celiac disease in a wider range of patients, including those with IgA deficiency. For instance, IgG anti-deamidated gliadin peptide antibodies (DGAB) are recommended for patients with low IgA levels, offering comparable diagnostic sensitivity to IgG anti-tTG for IgA-deficient celiac patients.Anti-Deamidated Gliadin Peptides (DGP) IgA
The anti-DGP IgA test is typically recommended in several scenarios:
* Suspected Celiac Disease: As part of a panel of tests to investigate symptoms suggestive of celiac disease, such as gastrointestinal issues, fatigue, or nutrient deficiencies.
* Confirmation of Diagnosis: To support a diagnosis when other markers like tTG IgA are positive or equivocal.
* Monitoring Treatment: To track the effectiveness of a gluten-free diet by observing changes in antibody levels over time.
* Patients with IgA Deficiency: In individuals known or suspected to have IgA deficiency, anti-DGP IgG may be preferred, or a combined IgA and IgG panel may be used.
* Dermatitis Herpetiformis: This skin manifestation of celiac disease often benefits from DGP testing.
In summary, the anti-deamidated gliadin peptide IgA test is a valuable tool in the comprehensive diagnostic approach to celiac disease. Its ability to detect specific antibodies against modified gliadin peptides contributes significantly to accurate diagnosis, especially when considered alongside other crucial celiac disease biomarkers and patient-specific factors like IgA levels.
Join the newsletter to receive news, updates, new products and freebies in your inbox.